# Capstone Energy Plus, Inc.: financial statements, quarterly

CEPL · Nasdaq · CIK 1009759 · [Industrials](/sectors/industrials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/cepl.md) · [Financials](/companies/cepl/financials.md) · [Filings](/companies/cepl/filings.md) · [Insiders](/companies/cepl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cepl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [28.4](/filings/0001558370-24-015283.md) | [14.6](/filings/0001558370-25-000958.md) | [24.3 d](/filings/0001558370-25-008930.md) | [15.6](/filings/0001558370-25-010824.md) | [22.7](/filings/0001104659-25-111319.md) | [20.1](/filings/0001104659-26-014292.md) | [27.1 d](/filings/0001104659-26-077817.md) | [27.9](/filings/0001104659-26-094889.md) | [28.4](/filings/0001104659-25-111319.md) | [26.8](/filings/0001104659-26-014292.md) | [23.0 d](/filings/0001104659-26-077817.md) | [24.9](/filings/0001104659-26-094889.md) |
| Cost of revenue | $m | [23.1](/filings/0001558370-24-015283.md) | [11.6](/filings/0001558370-25-000958.md) | [21.8 d](/filings/0001558370-25-008930.md) | [11.9](/filings/0001558370-25-010824.md) | [15.7](/filings/0001104659-25-111319.md) | [15.2](/filings/0001104659-26-014292.md) | [19.5 d](/filings/0001104659-26-077817.md) | [20.3](/filings/0001104659-26-094889.md) | [19.4](/filings/0001104659-25-111319.md) | [16.3](/filings/0001104659-26-014292.md) | [16.1 d](/filings/0001104659-26-077817.md) | [16.2](/filings/0001104659-26-094889.md) |
| Gross profit | $m | [5.3](/filings/0001558370-24-015283.md) | [3.0](/filings/0001558370-25-000958.md) | [2.6 d](/filings/0001558370-25-008930.md) | [3.8](/filings/0001558370-25-010824.md) | [7.0](/filings/0001104659-25-111319.md) | [5.0](/filings/0001104659-26-014292.md) | [7.5 d](/filings/0001104659-26-077817.md) | [7.6](/filings/0001104659-26-094889.md) | [9.0](/filings/0001104659-25-111319.md) | [10.4](/filings/0001104659-26-014292.md) | [6.9 d](/filings/0001104659-26-077817.md) | [8.8](/filings/0001104659-26-094889.md) |
| Research and development | $m | [0.7](/filings/0001558370-24-015283.md) | [0.6](/filings/0001558370-25-000958.md) | [0.6 d](/filings/0001558370-25-008930.md) | [0.5](/filings/0001558370-25-010824.md) | [0.6](/filings/0001104659-25-111319.md) | [0.7](/filings/0001104659-26-014292.md) | [0.8 d](/filings/0001104659-26-077817.md) | [0.8](/filings/0001104659-26-094889.md) | [0.8](/filings/0001104659-25-111319.md) | [1.0](/filings/0001104659-26-014292.md) | [1.0 d](/filings/0001104659-26-077817.md) | [1.2](/filings/0001104659-26-094889.md) |
| Selling, general and administrative | $m | [9.2](/filings/0001558370-24-015283.md) | [9.7](/filings/0001558370-25-000958.md) | [6.5 d](/filings/0001558370-25-008930.md) | [6.8](/filings/0001558370-25-010824.md) | [6.4](/filings/0001104659-25-111319.md) | [6.3](/filings/0001104659-26-014292.md) | [6.7 d](/filings/0001104659-26-077817.md) | [6.9](/filings/0001104659-26-094889.md) | [6.8](/filings/0001104659-25-111319.md) | [7.4](/filings/0001104659-26-014292.md) | [5.7 d](/filings/0001104659-26-077817.md) | [6.6](/filings/0001104659-26-094889.md) |
| Operating income | $m | [(4.6)](/filings/0001558370-24-015283.md) | [(7.3)](/filings/0001558370-25-000958.md) | [(4.5) d](/filings/0001558370-25-008930.md) | [(3.5)](/filings/0001558370-25-010824.md) | [0.0](/filings/0001104659-25-111319.md) | [(2.1)](/filings/0001104659-26-014292.md) | [0.0 d](/filings/0001104659-26-077817.md) | [(0.2)](/filings/0001104659-26-094889.md) | [1.4](/filings/0001104659-25-111319.md) | [2.0](/filings/0001104659-26-014292.md) | [0.2 d](/filings/0001104659-26-077817.md) | [1.0](/filings/0001104659-26-094889.md) |
| Interest expense | $m | [1.8](/filings/0001558370-24-010759.md) | [1.1](/filings/0001558370-24-012687.md) | [0.9 d](/filings/0001558370-25-008930.md) | [1.0](/filings/0001558370-25-010824.md) | [1.0](/filings/0001104659-25-111319.md) | [1.0](/filings/0001104659-26-014292.md) | [0.9 d](/filings/0001104659-26-077817.md) | [1.0](/filings/0001104659-26-094889.md) | [1.1](/filings/0001104659-25-111319.md) | [1.1](/filings/0001104659-26-014292.md) | [0.9 d](/filings/0001104659-26-077817.md) | [0.9](/filings/0001104659-26-094889.md) |
| Income tax | $m | [(0.0)](/filings/0001558370-24-015283.md) | [(0.0)](/filings/0001558370-25-000958.md) | [0.0 d](/filings/0001558370-25-008930.md) | [0.0](/filings/0001558370-25-010824.md) | [0.0](/filings/0001104659-25-111319.md) | [0.0](/filings/0001104659-26-014292.md) | [0.1 d](/filings/0001104659-26-077817.md) | [0.0](/filings/0001104659-26-094889.md) | [0.0](/filings/0001104659-25-111319.md) | [0.0](/filings/0001104659-26-014292.md) | [(0.1) d](/filings/0001104659-26-077817.md) | [0.0](/filings/0001104659-26-094889.md) |
| Net income | $m | [(5.9)](/filings/0001558370-25-000958.md) | [24.2](/filings/0001558370-25-000958.md) | [(5.3) d](/filings/0001558370-25-008930.md) | [(3.9)](/filings/0001104659-26-014292.md) | [(0.4)](/filings/0001104659-26-014292.md) | [(2.7)](/filings/0001104659-26-014292.md) | [(0.1) d](/filings/0001104659-26-077817.md) | [(0.7)](/filings/0001104659-26-094889.md) | [0.8](/filings/0001104659-26-014292.md) | [1.2](/filings/0001104659-26-014292.md) | [1.5 d](/filings/0001104659-26-077817.md) | [0.0](/filings/0001104659-26-094889.md) |
| Diluted EPS | $ per share | [(0.32)](/filings/0001558370-24-015283.md) | [1.27](/filings/0001558370-25-000958.md) | not reported | [(0.21)](/filings/0001558370-25-010824.md) | [(0.02)](/filings/0001104659-25-111319.md) | [(0.14)](/filings/0001104659-26-014292.md) | not reported | [(0.04)](/filings/0001104659-26-094889.md) | [(0.89)](/filings/0001104659-25-111319.md) | [(1.79)](/filings/0001104659-26-014292.md) | not reported | [(0.03)](/filings/0001104659-26-094889.md) |
| Basic EPS | $ per share | [(0.32)](/filings/0001558370-24-015283.md) | [1.27](/filings/0001558370-25-000958.md) | not reported | [(0.21)](/filings/0001558370-25-010824.md) | [(0.02)](/filings/0001104659-25-111319.md) | [(0.14)](/filings/0001104659-26-014292.md) | not reported | [(0.04)](/filings/0001104659-26-094889.md) | [(0.89)](/filings/0001104659-25-111319.md) | [(1.79)](/filings/0001104659-26-014292.md) | not reported | [(0.03)](/filings/0001104659-26-094889.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.5](/filings/0001558370-24-010759.md) | [3.9](/filings/0001558370-24-012687.md) | [2.1](/filings/0001558370-25-008930.md) | [4.0](/filings/0001558370-24-013373.md) | [2.7](/filings/0001558370-24-015283.md) | [3.3](/filings/0001558370-25-000958.md) | [8.7](/filings/0001104659-26-077817.md) | [6.6](/filings/0001558370-25-010824.md) | [7.0](/filings/0001104659-25-111319.md) | [14.4](/filings/0001104659-26-014292.md) | [28.2](/filings/0001104659-26-077817.md) | [31.6](/filings/0001104659-26-094889.md) |
| Current assets | $m | [47.6](/filings/0001558370-24-010759.md) | [46.8](/filings/0001558370-24-012687.md) | [34.7](/filings/0001558370-25-008930.md) | [35.8](/filings/0001558370-24-013373.md) | [35.4](/filings/0001558370-24-015283.md) | [38.0](/filings/0001558370-25-000958.md) | [36.1](/filings/0001104659-26-077817.md) | [37.5](/filings/0001558370-25-010824.md) | [42.9](/filings/0001104659-25-111319.md) | [50.2](/filings/0001104659-26-014292.md) | [67.8](/filings/0001104659-26-094889.md) | [76.1](/filings/0001104659-26-094889.md) |
| Total assets | $m | [99.1](/filings/0001558370-24-010759.md) | [97.7](/filings/0001558370-24-012687.md) | [84.2](/filings/0001558370-25-008930.md) | [83.5](/filings/0001558370-24-013373.md) | [78.3](/filings/0001558370-24-015283.md) | [78.4](/filings/0001558370-25-000958.md) | [74.9](/filings/0001104659-26-077817.md) | [72.8](/filings/0001558370-25-010824.md) | [82.4](/filings/0001104659-25-111319.md) | [87.7](/filings/0001104659-26-014292.md) | [111](/filings/0001104659-26-094889.md) | [115](/filings/0001104659-26-094889.md) |
| Current liabilities | $m | [63.1](/filings/0001558370-24-010759.md) | [56.1](/filings/0001558370-24-012687.md) | [73.2](/filings/0001558370-25-008930.md) | [47.8](/filings/0001558370-24-013373.md) | [43.2](/filings/0001558370-24-015283.md) | [53.6](/filings/0001558370-25-000958.md) | [52.6](/filings/0001104659-26-077817.md) | [51.7](/filings/0001558370-25-010824.md) | [57.2](/filings/0001104659-25-111319.md) | [73.1](/filings/0001104659-26-014292.md) | [70.8](/filings/0001104659-26-094889.md) | [75.9](/filings/0001104659-26-094889.md) |
| Total liabilities | $m | [77.5](/filings/0001558370-24-010759.md) | [93.3](/filings/0001558370-24-012687.md) | [85.0](/filings/0001558370-25-008930.md) | [88.1](/filings/0001558370-24-013373.md) | [83.3](/filings/0001558370-24-015283.md) | [86.0](/filings/0001558370-25-000958.md) | [82.6](/filings/0001104659-26-077817.md) | [80.9](/filings/0001558370-25-010824.md) | [89.7](/filings/0001104659-25-111319.md) | [80.1](/filings/0001104659-26-014292.md) | [82.0](/filings/0001104659-26-094889.md) | [85.1](/filings/0001104659-26-094889.md) |
| Long-term debt | $m | not reported | not reported | [28.9](/filings/0001558370-24-013052.md) | [29.8](/filings/0001558370-24-013373.md) | [30.9](/filings/0001558370-24-015283.md) | [31.7](/filings/0001558370-25-000958.md) | [24.2](/filings/0001104659-26-077817.md) | [24.6](/filings/0001558370-25-010824.md) | [25.0](/filings/0001104659-25-111319.md) | [25.3](/filings/0001104659-26-014292.md) | [25.3](/filings/0001104659-26-077817.md) | [25.3](/filings/0001104659-26-094889.md) |
| Current portion of debt | $m | not reported | not reported | [28.9](/filings/0001558370-25-008930.md) | not reported | not reported | not reported | [8.0](/filings/0001104659-26-077817.md) | [8.1](/filings/0001558370-25-010824.md) | [8.2](/filings/0001104659-25-111319.md) | [25.3](/filings/0001104659-26-014292.md) | [25.3](/filings/0001104659-26-094889.md) | [25.3](/filings/0001104659-26-094889.md) |
| Shareholders' equity | $m | [(35.3)](/filings/0001558370-24-012687.md) | [(9.4)](/filings/0001558370-24-012687.md) | [(14.6)](/filings/0001558370-25-008930.md) | [(18.5)](/filings/0001558370-24-013373.md) | [(18.9)](/filings/0001558370-24-015283.md) | [(21.5)](/filings/0001558370-25-000958.md) | [(21.6)](/filings/0001104659-26-077817.md) | [(22.0)](/filings/0001558370-25-010824.md) | [(39.4)](/filings/0001104659-25-111319.md) | [(63.3)](/filings/0001104659-26-014292.md) | [(44.5)](/filings/0001104659-26-094889.md) | [(45.2)](/filings/0001104659-26-094889.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.6) d](/filings/0001558370-24-015283.md) | [(12.7) d](/filings/0001558370-25-000958.md) | [(5.6) d](/filings/0001558370-25-008930.md) | [2.1](/filings/0001558370-25-010824.md) | [(1.2) d](/filings/0001104659-25-111319.md) | [1.3 d](/filings/0001104659-26-014292.md) | [5.5 d](/filings/0001104659-26-077817.md) | [(1.6)](/filings/0001104659-26-094889.md) | [0.6 d](/filings/0001104659-25-111319.md) | [3.0 d](/filings/0001104659-26-014292.md) | [(4.5) d](/filings/0001104659-26-077817.md) | [5.4](/filings/0001104659-26-094889.md) |
| Capital expenditure | $m | [1.7 d](/filings/0001558370-24-015283.md) | [0.6 d](/filings/0001558370-25-000958.md) | [0.1 d](/filings/0001558370-25-008930.md) | [0.1](/filings/0001558370-25-010824.md) | [0.0 d](/filings/0001104659-25-111319.md) | [0.7 d](/filings/0001104659-26-014292.md) | [0.0 d](/filings/0001104659-26-077817.md) | [0.1](/filings/0001104659-26-094889.md) | [0.3 d](/filings/0001104659-25-111319.md) | [0.4 d](/filings/0001104659-26-014292.md) | [0.1 d](/filings/0001104659-26-077817.md) | [0.9](/filings/0001104659-26-094889.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001104659-26-094889.md) | [0.1 d](/filings/0001104659-25-111319.md) | [0.0 d](/filings/0001104659-26-014292.md) | not reported | [0.2](/filings/0001104659-26-094889.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.8](/filings/0001558370-24-010759.md) | [18.4](/filings/0001558370-24-012687.md) | [18.4](/filings/0001558370-24-013373.md) | [18.5](/filings/0001558370-24-015283.md) | [19.0](/filings/0001558370-25-000958.md) | [19.0](/filings/0001558370-25-010824.md) | [19.0](/filings/0001104659-25-111319.md) | [19.0](/filings/0001104659-26-014292.md) | [19.4](/filings/0001104659-26-094889.md) | [19.4](/filings/0001104659-25-111319.md) | [21.1](/filings/0001104659-26-014292.md) | [34.3](/filings/0001104659-26-094889.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,546,649 at 2024-06-10, from the cover of the [10-K filed 2024-06-13](/filings/0001558370-24-009109.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.